afamelanotide (melanotan i) mastery course
Unit 5 of 12

Pivotal Trials in EPP

Endpoint design, efficacy interpretation, and the real clinical meaning of light tolerance.

Reading the Trials

The clinical story is strongest when you read the pivotal EPP trials as disease-function studies, not as vague evidence for generic tanning claims.


Interactive Endpoint Explorer

A quick visual on how baseline, trial exposure, and interpretation fit together.

light-tolerance timeline

Trial Design

Population, design logic, and what the studies were trying to capture.


Endpoints

Why pain-free light exposure and quality of life matter here.


Efficacy Results

What the pivotal program actually showed.


Limitations

What the trials did not prove and where sloppy interpretations begin.